Cardinal Health’s CAH Monoject syringes get unfavorable FDA recommendation following reports of delay in therapy as well as inaccurate therapy (overdose or underdose) when used with a syringe pump or ...

Only days after MD+DI reported Cardinal Health was embroiled in a Class I recall of its Cardinal branded Monoject syringes, FDA has moved to clarify its advice for clinicians specific to the recall.

The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports ...

The Food and Drug Administration voiced concerns in a Monday letter that Cardinal Health failed to sufficiently mitigate the risk of incompatibility between its syringes and certain pumps in its ...

The U.S. FDA advises health care providers (HCPs) to avoid using Monoject syringes distributed by Cardinal Health with syringe pumps or patient-controlled analgesia (PCA) pumps because of ...

Just a week after issuing a notice giving its most serious rating to Cardinal Health’s recall of certain syringes, the FDA has put out a letter to healthcare providers warning that the recall may not ...

The FDA has doled out its most serious classification to a recall of some Cardinal Health medical supplies. In this case, the recall doesn’t describe a product removal, but merely a correction to the ...

Cardinal Health revised its product correction for more than 27 million syringes on Feb 2, and the FDA upgraded the notice to a Class I recall — the most serious type. Because of a change in ...

WASHINGTON, Aug. 20 (UPI) -- Covidien, a healthcare products producer, initiated a voluntary recall of certain lots of Monoject prefill flush syringes, U.S. government officials say. The U.S. Food and ...